检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李眺[1] 陈利国[2] 李权 周永红[2] 唐海兰[2] 程少冰[2]
机构地区:[1]珠海市人民医院,珠海519000 [2]暨南大学,广州510632 [3]秦皇岛市中医院,秦皇岛066000
出 处:《中华中医药杂志》2011年第11期2672-2675,共4页China Journal of Traditional Chinese Medicine and Pharmacy
基 金:国家自然科学基金项目(No.30572289);广东省自然科学基金项目(No.5006019)~~
摘 要:目的:探讨川芎嗪(TMP)、黄芪多糖(APS)及其配伍对血管内皮细胞(VECs)的保护作用。方法:用浓度为10%高血压病患者血清作用于脐静脉内皮细胞株(ECV-304)24h进行造模,实验分为模型组、对照组、TMP组、APS组、TMP与APS配伍组。其中药物各组是将患者血清与药物共同培育细胞。以四甲基偶氮唑盐(MTT)法检测细胞活性,硝酸还原酶法检测一氧化氮(NO)浓度,非平衡法测定内皮素(ET),激光扫描共聚焦显微镜检测细胞内游离钙浓度。结果:各药物组浓度依赖性增强细胞活性、增加NO释放、而抑制细胞ET释放、增加胞内游离钙浓度,且这两个中药单体配伍后比单独使用作用更显著。结论:TMP、APS及其配伍对VECs具有明显保护作用,且两者可能存在一定的协调作用。Objective: To study the protective effects of tetramethylpyrazine(TMP),astragalus polysaccharides(APS) and their combination on vascular endothelial cells(VECs).Methods: To establish the cell model,We selected that the serum concentrations was 10% and the time was 24h,at the same time ECV-304 were processed by TMP,APS and their different combinations.Experiments were divided into 5 groups: the model group,the control group,the TMP groups,the APS groups and the monomer combination groups.the activeness of cultivated ECV-304 were assayed by MTT chromatometry,the nitric oxide(NO) excreted by the cells was assayed by nitric acid deoxidizing enzyme method,and the endothelin(ET) was assayed by non-balance method,the cells' intracellular free calcium(i) was assayed by laser scanning confocal microscope(LSCM).Results: Medicine groups could strengthen cells' activeness,increased the NO level,decreased ET level and cells' intracellular free calcium significantly compared with the model group.Conclusion: We considered that TMP and ASP has the distinct protective effects on VECs.We also found that TMP combined with APS was superior to a single medicine on the protective effects on VECs.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222